Epidemiology and management of hyperlipidemia.
Karr S.
Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148.
Hyperlipidemia.
Stewart J, McCallin T, Martinez J, Chacko S, Yusuf S.
Pediatr Rev. 2020 Aug;41(8):393-402. doi: 10.1542/pir.2019-0053.
Pediatric hyperlipidemia.
Garg A, Radhakrishnan S.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S104-S107. doi: 10.1016/j.ihj.2023.11.269. Epub 2024 Apr 8.
Lipid metabolism and hyperlipidemia in dogs.
Xenoulis PG, Steiner JM.
Vet J. 2010 Jan;183(1):12-21. doi: 10.1016/j.tvjl.2008.10.011. Epub 2009 Jan 23.
Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review.
Yao YS, Li TD, Zeng ZH.
Lipids Health Dis. 2020 Feb 8;19(1):23. doi: 10.1186/s12944-019-1171-8.
Hyperlipidemia.
Kreisberg RA.
Curr Ther Endocrinol Metab. 1997;6:509-19.
Hyperlipidemia in children.
McCrindle BW.
Thromb Res. 2006;118(1):49-58. doi: 10.1016/j.thromres.2005.01.006. Epub 2005 Feb 17.
The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review.
Husain MJ, Spencer G, Nugent R, Kostova D, Richter P.
Glob Heart. 2022 Mar 4;17(1):18. doi: 10.5334/gh.1097. eCollection 2022.
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases.
Lai M, Peng H, Wu X, Chen X, Wang B, Su X.
Int Immunopharmacol. 2022 Jul;108:108876. doi: 10.1016/j.intimp.2022.108876. Epub 2022 May 24.
Hyperlipidemia.
Yu JN, Cunningham JA, Thouin SR, Gurvich T, Liu D.
Prim Care. 2000 Sep;27(3):541-87,v. doi: 10.1016/s0095-4543(05)70164-0.
